Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

NCT01360645 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

826

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder
Depression
Depressive Disorder, Major
Mood Disorders
Mental Disorders

Interventions

DRUG: OPC-34712 + ADT
DRUG: Placebo + ADT
DRUG: Placebo + ADT

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.